Novavax shares spike over 100% on Sanofi deal to commercialize Covid vaccine, develop combination shots

[ad_1]

The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.

[ad_2]

Source link